Literature DB >> 1508245

Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes.

A L Usala1, T Madigan, B Burguera, M K Sinha, J F Caro, P Cunningham, J G Powell, P C Butler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1508245     DOI： 10.1056/NEJM199209173271205

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.

Authors:  Z Laron
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

2.  Insulin-like growth factor-I in Helicobacter pylori gastritis and response to eradication using bismuth based triple therapy.

Authors:  A S Taha; G Beastall; R Morton; R H Park; A D Beattie
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

3.  Stimulation of glucose uptake by insulin-like growth factor II in human muscle is not mediated by the insulin-like growth factor II/mannose 6-phosphate receptor.

Authors:  B Burguera; C W Elton; J F Caro; E B Tapscott; W J Pories; R Dimarchi; K Sakano; G L Dohm
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

Review 4.  Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.

Authors:  N Mauras; M W Haymond
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

5.  Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.

Authors:  R Laager; U Keller
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.